Saniona
4.4 SEK +17.96%2 investors are following this company
Saniona is active in biotechnology. Today, research and development of drugs for the treatment of nerve diseases and other autoimmune diseases are conducted. The drug portfolio is broad and includes drugs that are currently in various clinical phases. Some of the work is also carried out in collaboration with other cooperation partners in the pharmaceutical industry. Saniona is headquartered in Glostrup.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
SANION
Daily low / high price
3.76 / 4.49
SEK
Market cap
489.45M SEK
Turnover
8.66M SEK
Volume
2M
Latest videos
Financial calendar
Interim report
29.08.2024
Interim report
28.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 8.7 % | 8.7 % |
Nordnet Pensionsförsäkring AB | 5.0 % | 5.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Saniona comments on article addressing the potential mechanism of action behind tesofensine’s unique weight loss effect
Redeye: Saniona Q1 - Pipeline progression
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools